Topical tofacitinib for the treatment of alopecia areata affecting facial hair.

Of 26 patients (17 male; nine female) with a median age of 30 years (range 6-54), 18 had eyebrow AA, four had eyelash AA and nine had beard AA (Table 1). Additionally, facial hair bulbs are more superficial than their scalp counterparts and may therefore be more accessible to topical therapies.8 Only four patients (two with eyebrow AA and two with beard AA) had been on concomitant systemic treatments for moderate-to-severe scalp AA for > 6 months with failure of any facial hair regrowth. Five patients had AA affecting two facial hair-bearing sites (two with eyebrow/beard; three with eyebrow/eyelash). [Extracted from the article]